LATEST NEWS
- 16Apr-2020
【Rapid Nucleic Acid Test of Coronavirus】Cepheid has developed an automated molecular test for the qualitative detection of SARS-CoV-2, the virus that causes COVID-19. The test can provide rapid detection of the current pandemic coronavirus SARS-CoV-2 in approximately 45 minutes with less than a minute of hands on time to prepare the sample. Cepheid’s Xpert® Xpress SARS-CoV-2 kits has received Emergency Use Authorization from US FDA. Progressive Group Inc. also has received TFDA’s Emergency USE Authorization on import of the kit on April 8, 2020.
- 31Mar-2020
【New Product Launch】Progressive Group Inc. launched 3M +KCI’s PREVENA Incision Management System, the first and only negative pressure medical device in the reduction of superficial surgical site infections (SSIs) in patients at a high risk for post-operative infections in wounds.
- 01Dec-2019
【Wound Care Collaboration】Progressive Group Inc. collaborated with Shuang Ho Hospital for comprehensive and better quality of wound care service for inpatient, outpatient and home care patients.
